# US 2006/0153912 A1 · Choline ascorbate formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153912 A1
- Document ID: US20060153912A1
- Status: Published application
- Kind: A1
- Application number: 10/528,697
- Filed: 2003-09-22
- Published: 2006-07-13
- Earliest claimed: 2002-09-24
- Assignees: BASF SE
- Inventors: Andreas Habich; Morten Hansen; Carsten Hansen; Brigitte Yde; Alfred Oftring; Michael Schoenherr; Felicitas Guth; Oliver Hasselwander
- Web page: https://patentgrep.com/patent/US20060153912A1

## CPC

- A61K 31/14: Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K31/205)
- A23K 20/105: Aliphatic or alicyclic compounds
- A23K 20/174: Vitamins
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/5015: {Organic compounds, e.g. fats, sugars}
- A61K 9/5057: {Gelatin}
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23K: FODDER
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The invention relates to novel choline ascorbate-containing formulations; processes for their preparation and their use in human or animal foods, or human or animal food supplements or pharmaceuticals.

## Claims

### Claim 1

A solid choline ascorbate formulation with reduced sensitivity to external stress factors, characterized in that a solution of this formulation has under standard conditions a Gardner color number (determined as specified in DIN-ISO 4630 or ASTM D 1544-80) of <4.5, and/or a Hazen color number (determined as specified in DIN-ISO 6271 or ASTM D 1045-68, ASTM D 26349 or ASTM D 1209-69) of <800; and does not deliquesce on storage under standard conditions in moist ambient air.

### Claim 2 (depends on 1)

A formulation as claimed in claim 1, wherein
a) choline ascorbate is surface-coated with an inert coating composition;
b) choline ascorbate is embedded in an inert matrix; or
c) a porous carrier is loaded with choline ascorbate, and the loaded carrier is surface-coated where appropriate with an inert coating composition.

### Claim 3

A formulation as claimed in any of the preceding claims, which additionally comprises an effective amount of at least one addition which further reduces the tendency to discoloration of choline ascorbate.

### Claim 4 (depends on 3)

A formulation as claimed in claim 3, wherein the addition which further reduces the tendency to discoloration of choline ascorbate is mixed with the choline ascorbate and/or is present in the surface coating, in the inert matrix or in the porous carrier.

### Claim 5 (depends on 3, 4)

A formulation as claimed in claim 3 or 4, wherein the stabilizer is present in a proportion of about 0.05 to 30 mol % based on the molar content of choline ascorbate.

### Claim 6 (depends on 3, 4)

A formulation as claimed in any of claims 3 to 4, wherein the stabilizer is selected from sulfur-containing, phosphorus-containing or boron-containing compounds; carboxylic acids and carboxylic acid derivatives; vitamins and vitamin precursors and derivatives; natural product mixtures; hydroxy- or alkoxyaromatic compounds; reductones or mixtures thereof.

### Claim 7 (depends on 6)

A formulation as claimed in claim 6, wherein
a. the sulfur-containing stabilizer is selected from cysteine, cystine, N-acetylcysteine, thioglycolate, glutathione, dihydrolipoic acid, lipoic acid, sodium dithionite, methionine and thiourea;
b. the phosphorus-containing stabilizer is selected from phosphorous and hypophosphorous acid;
c. the boron-containing stabilizer is phenylboronic acid;
d. the carboxylic acids and carboxylic acid derivatives are selected from uric, lactic, malic, citric and excess ascorbic acid; and ascorbyl palmitate;
e. the vitamins, vitamin precursors and derivatives are selected from alpha-, beta- and gamma-tocopherol, tocotrienol and more water-soluble vitamin E derivatives; carotenoids; isoflavones; flavonoids and other naturally occurring polyphenols;
f. the natural product mixture is a rosemary extract;
g. the reductone is hydroxyacetone; and
h. the hydroxy- or alkoxy-aromatic compounds are selected from 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline (ethoxyquin), t-butylhydroxytoluene and t-butylhydroxyanisole;
or the stabilizer is a functional derivative, having a stabilizing action, of one of the above compounds.

### Claim 8

A formulation as claimed in any of the preceding claims, wherein the choline ascorbate content is in a range from about 5 to 95% by weight based on the total weight of the formulation.

### Claim 9

A formulation as claimed in any of the preceding claims, which is coated with a coating composition comprising at least one compound selected from:
a) polyalkylene glycols;
b) polyalkylene oxide polymers or copolymers;
c) substituted polystyrenes, maleic acid derivatives and styrene/maleic acid copolymers;
d) vinyl polymers either alone or in combination with other compounds, such as cellulose ethers or starches;
e) vinylpyrrolidone/vinyl acetate copolymers;
f) polyvinyl alcohols, and polyphthalic acid vinyl esters;
g) hydroxypropylmethylcelluloses;
h) alkyl (meth)acrylate polymers and copolymers;
i) polyvinyl acetates, where appropriate stabilized with polyvinylpyrrolidone;
j) polyalkylenes;
k) aromatic polymers;
l) polyacrylic acids;
m) polyacrylamides;
n) polycyanoacrylates;
o) phenoxyacetic acid/formaldehyde resins;
p) cellulose derivatives;
q) animal, vegetable or synthetic fats and modified fats;
r) animal and vegetable waxes or chemically modified animal and vegetable waxes;
s) animal and vegetable proteins;
t) mono- and disaccharides, oligosaccharides, polysaccharides;
u) vegetable oils, synthetic or semisynthetic oils and animal oils;
v) hardened (hydrogenated or partially hydrogenated) oils/fats;
w) lacquer coatings;
x) fatty acids;
y) silicas;
or mixtures thereof.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

A formulation as claimed in any of claims 1 to 8, wherein the choline ascorbate is embedded in a matrix which comprises at least one compound as defined in claim 9 which is suitable for forming a matrix which is solid at a temperature in the range from about 20 to 100° C.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A formulation as claimed in any of claims 1 to 8, which comprises a porous carrier selected from silicates.

### Claim 12 (depends on 9)

A process for preparing a choline ascorbate-containing formulation as claimed in any of the preceding claims, which comprises solid choline ascorbate particles being coated by being
a. sprayed in a fluidized bed with a melt, a solution or a dispersion of a coating composition as defined in claim 9, or subjected to a powder coating with the coating composition in a fluidized bed; or
b. coated in a mixer with a melt, a solution or a dispersion of the coating composition, or subjected to a powder coating with the coating composition; or
c. mixed with fat, and the fat being melted by mechanical energy input and/or heating, while mixing is continued;
and the coated material obtained in each case where appropriate being dried, cooled and/or freed of coarse fractions.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises solid choline ascorbate particles being suspended in a melt comprising a (fusible) coating composition as defined in claim 9, and the suspension obtained in this way being dispersed and subsequently solidified.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises solid choline ascorbate particles being dispersed in a lipophilic environment, the solid/oil droplets obtained in this way being emulsified in an aqueous phase, and the emulsion being spray-formulated.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises choline ascorbate particles being coated by coacervation.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises an aqueous protective colloid solution being prepared, choline ascorbate being dissolved or dispersed therein, and the resulting mixture subsequently being spray-formulated or spray-dried and subsequently coated where appropriate.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises an aqueous choline ascorbate-containing solution being spray-dried in a fluidized bed and being granulated or agglomerated by addition of suitable additives.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises a solution, emulsion or suspension comprising choline ascorbate being mixed with a porous carrier and dried where appropriate; or a melt comprising choline ascorbate being applied to the porous carrier.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises wet granules comprising a choline ascorbate-containing solution or dispersion or a choline ascorbate-containing melt and a carrier, or comprising solid, crystalline or amorphous choline ascorbate, being prepared, the wet granules being extruded, where appropriate after-treated, dried and subsequently coated where appropriate.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises an aqueous solution of choline ascorbate being prepared, the latter being emulsified in a hydrophobic melt, and the emulsion being solidified.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A process for preparing a choline ascorbate-containing formulation as claimed in any of claims 1 to 8, which comprises a melt comprising choline ascorbate being atomized where appropriate in the presence of a dusting agent in a stream of cold gas.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

A human or animal food which, besides conventional ingredients of human or animal foods, comprises a choline ascorbate-containing formulation as defined in any of claims 1 to 11 in a proportion of about 0.001 to 50% by weight.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

A human or animal food supplement which, besides conventional ingredients of human or animal food supplements, comprises a choline ascorbate-containing formulation as defined in any of claims 1 to 11 in a proportion of about 0.01 to 99.9% by weight.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

A pharmaceutical in solid, liquid or pasty form, which comprises in a pharmaceutically suitable carrier an effective amount of a choline ascorbate-containing formulation as claimed in any of claims 1 to 11.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The use of a choline ascorbate-containing formulation as claimed in any of claims 1 to 11 for preparing human and animal foods, and human and animal food supplements, or pharmaceuticals.
